Ye Qilu, Henrickson Amy, Demeler Borries, Serrão Vitor Hugo Balasco, Davies Peter L
Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, K7L 3N6, Canada.
Department of Chemistry & Biochemistry, University of Lethbridge, Lethbridge, AB, T1K 3M4, Canada.
bioRxiv. 2024 Mar 3:2024.02.28.582628. doi: 10.1101/2024.02.28.582628.
Calpain-3 is an intracellular Ca-dependent cysteine protease abundant in skeletal muscle. Its physiological role in the sarcomere is thought to include removing damaged muscle proteins after exercise. Loss-of-function mutations in its single-copy gene cause a dystrophy of the limb-girdle muscles. These mutations, of which there are over 500 in humans, are spread all along this 94-kDa multi-domain protein that includes three 40+-residue sequences (NS, IS1, and IS2). The latter sequences are unique to this calpain isoform and are hypersensitive to proteolysis. To investigate the whole enzyme structure and how mutations might affect its activity, we produce the proteolytically more stable 85-kDa calpain-3 ΔNS ΔIS1 form with a C129A inactivating mutation as a recombinant protein in During size-exclusion chromatography, this calpain-3 was consistently eluted as a much larger 0.5-MDa complex rather than the expected 170-kDa dimer. Its size, which was confirmed by SEC-MALS, Blue Native PAGE, and AUC, made the complex amenable to single-particle cryo-EM analysis. From two data sets, we obtained a 3.85-Å reconstruction map that shows the complex is a trimer of calpain-3 dimers with six penta-EF-hand domains at its core. Calpain-3 has been reported to bind the N2A region of the giant muscle protein titin. When this 37-kDa region of titin was co-expressed with calpain-3 the multimer was reduced to a 320-kDa particle, which appears to be the calpain dimer bound to several copies of the titin fragment. We suggest that newly synthesized calpain-3 is kept as an inactive hexamer until it binds the N2A region of titin in the sarcomere, whereupon it dissociates into functional dimers.
钙蛋白酶-3是一种细胞内钙依赖性半胱氨酸蛋白酶,在骨骼肌中含量丰富。它在肌节中的生理作用被认为包括在运动后清除受损的肌肉蛋白。其单拷贝基因的功能丧失突变会导致肢带肌营养不良。这些突变在人类中有500多种,分布在这种94 kDa的多结构域蛋白上,该蛋白包括三个40多个残基的序列(NS、IS1和IS2)。后两个序列是这种钙蛋白酶异构体所特有的,并且对蛋白水解高度敏感。为了研究整个酶的结构以及突变如何影响其活性,我们在大肠杆菌中作为重组蛋白生产了具有C129A失活突变的蛋白水解稳定性更高的85 kDa钙蛋白酶-3 ΔNS ΔIS1形式。在尺寸排阻色谱过程中,这种钙蛋白酶-3始终以大得多的0.5 MDa复合物形式洗脱,而不是预期的170 kDa二聚体。通过SEC-MALS、蓝色天然PAGE和AUC确认的其大小,使得该复合物适合进行单颗粒冷冻电镜分析。从两个数据集,我们获得了一个3.85 Å的重建图谱,显示该复合物是钙蛋白酶-3二聚体的三聚体,其核心有六个五聚EF手结构域。据报道,钙蛋白酶-3与巨大肌肉蛋白肌联蛋白的N2A区域结合。当肌联蛋白的这个37 kDa区域与钙蛋白酶-3共表达时,多聚体减少到一个320 kDa的颗粒,这似乎是与几个肌联蛋白片段拷贝结合的钙蛋白酶二聚体。我们认为,新合成的钙蛋白酶-3保持为无活性的六聚体,直到它在肌节中与肌联蛋白的N2A区域结合,随后解离为功能性二聚体。